title: Cardiovascular side effects of newer antidepressants.
abstract: We review the cardiovascular effects of newer antidepressants. Although further studies are warranted, the safety of the selective serotonin reuptake inhibitors and the serotonin norepinephrine reuptake inhibitors on patients with comorbid cardiac conditions is impressive. Newer antidepressants should be considered as first-line agents for the treatment of depression in patients with and without cardiovascular disease.
authors.affiliation: Psychiatry Service, Hunter Holmes McGuire Veterans Affairs Medical Center and Department of Psychiatry, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia, USA.
authors.forename: Antony
authors.initials: A
authors.lastname: Fernandez
authors.forename: Suji E
authors.initials: SE
authors.lastname: Bang
authors.forename: Komandur
authors.initials: K
authors.lastname: Srivathsan
authors.forename: W Victor R
authors.initials: WV
authors.lastname: Vieweg
mesh_terms: D000928:Antidepressive Agents / Q000009:adverse effects*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D016757:Death, Sudden, Cardiac; D003866:Depressive Disorder / Q000188:drug therapy; D006801:Humans; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects